Duragen® Secure Post Marketing Clinical Follow-up (PMCF)

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Dura Mater Nick Cut or TearSurgery
Trial Locations (5)

Unknown

Hopital Lariboisière, Paris

die Charité - Universitätsmedizin Berlin, Berlin

Hospital Universitario 12 de Octubre, Madrid

Hospital Universitario La Fe, Valencia

National Hospital for Neurology and Neurosurgery, London

All Listed Sponsors
lead

Integra LifeSciences Corporation

INDUSTRY

NCT02225080 - Duragen® Secure Post Marketing Clinical Follow-up (PMCF) | Biotech Hunter | Biotech Hunter